Philippe Moullier, MD, PhD

“The advancements we have made to create better and more powerful AAV vectors are transforming the future of gene therapeutics.”

Philippe Moullier, MD, PhD

Chief Scientific Officer, AskBio Europe

Philippe Moullier is a world-renowned expert in viral vector development and gene therapy translational research and joined AskBio in 2018. Prior to that, he was a founder and Chief Scientific Officer of HORAMA, a company dedicated to gene therapy for retinal diseases. He previously served as research director at INSERM (UMR1089) and founded the Institute for Gene Therapy at Nantes University Hospital (France), which he directed until 2016.

Dr. Moullier has served as an expert consultant to French (ANSM) and European (EMA) regulatory bodies and was an adjunct professor at the University of Florida from 2006 through 2015. He has authored more than 120 publications in the field of gene therapy and genetics. Dr. Moullier holds a master’s degree in immunology from the Pasteur Institute and a PhD in biochemistry from the University of Paris. He was a postdoctoral fellow at Scripps Research Institute in La Jolla. Dr. Moullier also was an intern in nephrology and internal medicine and received his MD degree from the University of Paris.